Venous Thromboembolism and Deep Vein Thrombosis
Clinical research at Ostfold Hospital Trust includes treatment and prevention strategies for venous thromboembolism, with a focus on deep vein thrombosis and pulmonary embolism. The funded studies examine recurrence risk and secondary prevention in patients with prior thrombotic events.
- Deep Vein Thrombosis
- Pulmonary Embolism
- Venous Thromboembolism
- Cardiovascular prevention
These studies reflect an interest in thrombotic disease management within hospital-based internal medicine and acute care settings.
Immune Thrombocytopenia and Haematology
The sponsor supports research in immune thrombocytopenia (ITP), concentrating on second-line management for adults who do not respond adequately to initial corticosteroid treatment. This area places emphasis on platelet-related immune disorders and specialist haematology care.
- Immune Thrombocytopenia (ITP)
- Platelet disorders
- Haematology
- Immune-mediated bleeding disorders
Research in this field addresses therapeutic options used in outpatient and specialist hospital services for complex blood disorders.
Major Depression Disorder and Treatment-Resistant Depression
Ostfold Hospital Trust also funds mental health research in major depression disorder (MDD), including work focused on treatment-resistant depression. The clinical interest lies in sustained symptom control for patients with persistent depressive illness.
- Major Depression Disorder (MDD)
- Treatment-resistant depression
- Psychiatry
- Mental health
This area connects hospital-based psychiatric care with interventions aimed at difficult-to-manage depressive disorders.
Hospital Clinical Research in Multisite Care
The sponsor’s research activity spans collaboration across multiple sites in Norway and beyond, supporting studies in internal medicine, haematology, and psychiatry. Its clinical portfolio includes conditions managed in both acute and specialist care environments.
- Internal medicine
- Psychiatry
- Haematology
- Multisite clinical research
These therapeutic areas align with the hospital trust’s role as a regional healthcare provider in Fredrikstad, Norway.
